▲Professor Lee Won-gu, Kosin University (Photo Credit=Anguk Pharm)
Ahn Kook Pharm announced on the 28th that it held a total of three web symposiums under the theme of’improving the quality of sleep without tolerance or habits’ in relation to’Melatonin’, a hypnotic sedative.
SeokatonpiR sustained-release tablet is a domestically licensed melatonin formulation. Through a web symposium, Ahn Kook Pharm re-examined melatonin preparations on various topics, including the importance of improving sleep quality, clinical guidelines for insomnia, and contributing to the discontinuation of psychotropic sleeping pills, and introduced the importance of improving sleep quality by patient case.
Lee Won-koo, a professor of neurology at Kosin University, who presented at this web symposium, said, “By improving sleep quality, the risk of developing degenerative brain diseases such as Alzheimer’s can be reduced.” I said.
PM Ahn Kook Pharm said, “Patients who have to take melatonin have not received active treatment due to the burden of drug price, but through the release of Circaton PIR sustained-release tablets, it is possible to actively treat patients with insufficient melatonin hormone concentration without burden of drug price.” Through quality improvement, we can improve the quality of life for menopausal women over the age of 55, obese patients, and patients with mild cognitive impairment.”
In a situation where the restrictions on offline business activities are increasing due to the continuous strengthening of social distancing, Ahn Kook Pharm changed the invitation letter for a symposium to an on-contact method in which medical experts were invited. In addition, by making the viewing method possible with a variety of mobile devices, access convenience has been greatly increased so as not to be restricted by the viewing location.
A company official said, “We will continue to strengthen our non-face-to-face sales marketing activities using online platforms that transcend time and place constraints.”